Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Roila

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2002
Quality of life as a primary end point in oncologyF Roila, E Cortesi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxisJ Herrstedt, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
The control of delayed nauseaF Roila, E Ballatori
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-upR Stupp, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxisJ Herrstedt, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Management of cancer pain: ESMO clinical recommendationsL Jost, F Roila,
Current Opinion in Oncology|August 14, 1998
The efficacy and cost-effectiveness of various antiemetic regimensF Roila, E Ballatori
Current Opinion in Oncology|July 1, 1997
Antiemetics revisitedF Roila, A Del Favero
Clinical Pharmacokinetics|August 1, 1995
Ondansetron clinical pharmacokineticsF Roila, A Del Favero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice GuidelinesD Bovelli, G Plataniotis, F Roila, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2002
Quality of life as a primary end point in oncologyF Roila, E Cortesi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxisJ Herrstedt, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
The control of delayed nauseaF Roila, E Ballatori
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-upR Stupp, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2009
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxisJ Herrstedt, F Roila,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Management of cancer pain: ESMO clinical recommendationsL Jost, F Roila,
Current Opinion in Oncology|August 14, 1998
The efficacy and cost-effectiveness of various antiemetic regimensF Roila, E Ballatori
Current Opinion in Oncology|July 1, 1997
Antiemetics revisitedF Roila, A Del Favero
Clinical Pharmacokinetics|August 1, 1995
Ondansetron clinical pharmacokineticsF Roila, A Del Favero
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice GuidelinesD Bovelli, G Plataniotis, F Roila, et al.
Pageof 12